EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma

Qing Xu, Xiangyu Hu, Ihsan Ullah, Taian Lin, Ye Liu, He Dong, Qingyu Zong, Youyong Yuan iD, Jun Wang

Advanced Materials · 2025-07 · 37 (29)

DOI: 10.1002/adma.202504253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.05.2025. Verfasst von Qing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, P.R. China. Hauptthemen laut MEDLINE: Glioblastoma, Temozolomide, Drug Resistance, Neoplasm, DNA Repair. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Pearl River Talents Program, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains one of the deadliest forms of cancer due to its high rates of postoperative recurrence and resistance to treatment. Temozolomide (TMZ) is the standard chemotherapy for GBM. However, the therapeutic efficacy of TMZ is significantly compromised by the activation of various intracellular DNA repair mechanisms that facilitate TMZ resistance. Herein, the upregulation of bromodomain‐containing protein 4 (BRD4) expression is demonstrated to be a key contributor to TMZ resistance in GBM. To address this challenge, a biomimetic hybrid PROteolysis TArgeting Chimeras (PROTAC) liposome delivery system (M@TP) is developed. This system efficiently penetrates the blood‐brain barrier (BBB) and specifically targets GBM cells through homotypic recognition. Once within TMZ‐resistant GBM cells, the released PROTAC from M@TP can specifically degrade BRD4, effectively inhibiting multiple DNA repair pathways and restoring sensitivity to TMZ treatment. In vivo, studies showed that M@TP demonstrated significant efficacy in suppressing tumor growth in both TMZ‐resistant and postoperative GBM, with prolonged mouse survival times. These findings highlight the potential of M@TP as a promising strategy to overcome TMZ resistance and improve therapeutic outcomes in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTemozolomideDrug Resistance, NeoplasmDNA RepairBiomimetic MaterialsBrain NeoplasmsAntineoplastic Agents, AlkylatingNanoparticlesHumansAnimalsCell Line, TumorMiceLiposomesTranscription FactorsCell Cycle ProteinsProteolysisBlood-Brain BarrierMice, NudeBromodomain Containing Proteins

Stichwörter der Autor:innen

PROTACbiomimetic nanotechnologydrug deliveryglioblastomatemozolomide resistance

Substanzen

TemozolomideLiposomesTranscription FactorsCell Cycle ProteinsAntineoplastic Agents, AlkylatingBRD4 protein, humanBromodomain Containing Proteins

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, P.R. China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, P.R. China.
  • Key Laboratory of Biomedical Engineering of Guangdong Province, South China University of Technology, Guangzhou, 510006, P. R. China.

ORCID-Profile: Youyong Yuan

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Pearl River Talents Program
  • Key Technologies Research and Development Program

Zitieren

APA

Xu, Q., Hu, X., Ullah, I., Lin, T., Liu, Y., Dong, H., Zong, Q., Yuan, Y., & Wang, J. (2025). Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma. Advanced Materials, 37(29). https://doi.org/10.1002/adma.202504253

Vancouver

Xu Q, Hu X, Ullah I, Lin T, Liu Y, Dong H, et al. Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma. Advanced Materials. 2025;37(29). doi:10.1002/adma.202504253

BibTeX
@article{Xu2025,
  author = {Xu, Qing and Hu, Xiangyu and Ullah, Ihsan and Lin, Taian and Liu, Ye and Dong, He and Zong, Qingyu and Yuan, Youyong and Wang, Jun},
  title = {Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {29},
  doi = {10.1002/adma.202504253}
}
Kostenlos starten →